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  Objectives: The incidence and risk factors of lympho 
 cele development after pelvic lymphadenectomy were  
evaluated and its management investigated.
  M ateria ls and M ethods: This re trospective  study was 
ca rrie d  out on  2 6 4  pa tie nts w ho re ce ive d a  pe lvic 
lymphadenectomy, be tween M a rch 19 99  a nd F ebruary 
2 0 0 3 ,  due  to gyne cologic ca nce r.  T he  pa tie nts we re  
classifie d into two groups; the  lymphoce le  (n=5 0 ) and 
non-lymphocele groups (n=214), as confirmed by ultraso-
nography, CT scan and M RI. Each group was compared
by cancer type and stage, BM I, preoperative Hb, use of 
pre/postoperative chemotherapy or radiotherapy, number 
of resected pelvic lymph nodes and the volume of 
postoperative drainage from a HemovacⓇ pelvic drain.
  Results: Of the 264 patients tested, 15 of 105 cervical 
cancer (14% ), 22 of 115 ovarian cancer (19%) and 11 of 
40 endometrial cancer patients (27% ), a total of 50  
patients (18% ), deve loped lymphoceles. In the lymph-
ocele  group (n=50), 13 patients were diagnosed with
complicated lymphocele. The BMI and number of resected 
pe lvic lym ph node s we re  found to  be  h ighe r in  the 
lymphoce le  tha n in the  non-lymphoce le  group (2 3 .9 4 ±
3.38 vs. 22.52±3.00, p=0.00 and 26.80±14.82 vs. 22.96±
10.18, p=0.03, respectively), and showed statistical signif-
icance. The occurrence of lymphoceles was lower without 
postoperative radiotherapy (p=0.01). 
  Conclusion: Among the 264 patients, a total of 50  
patients (18% ) developed lymphoceles. The BMI and 
number of resected lymph nodes were higher in the  
lymphocele group, and the use of postoperative radio- 
therapy was associated with a higher risk of lymphoceles. 
Thirteen of the 50 patients that developed lymphoceles 
(n=50) required treatment for lymphocele-related compli-
cations. (Cancer Research  and  Treatment 2004;36:377-383)
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INTRODUCTION
  Pelvic lymphadenectomy is commonly used to assess lymph 
node status, evaluate the stage and for treating gynecologic 
malignancies, and is often accompanied by complications, such 
as hemorrhage or hematoma, postoperative ileus and lympho-
cele. Of these complications, lymphocele is one of the most 
common postoperative complications (1).
  The definition of a lymphocele is a lymph-filled extra-
peritoneal space, with no epithelial lining. Most lymphoceles 
occur within 3~8 weeks, but may occur 1 year after surgery. 
Previous authors have reported a high incidence of lymphocele 
after a pelvic lymphadenectomy. Mori, for example, reported 
an average incidence of 48.5% (1). However, more recent series 
have reported much lower incidences. Ilancheran et al. noted 
an incidence of 25.3% in clinically diagnosable lymphocele 
with cervical cancer (2), Conte et al. noted an incidence of 22% 
in cervical cancer (3), Logmans et al. an incidence of 20~32% 
in gynecologic cancer (4) and Panici et al. an incidence of 
10~25% in gynecologic cancer (5). The reported incidences of 
lymphoceles following pelvic lymphadenectomy vary, which is 
probably related to the method of identification used. Whereas, 
clinical examination alone may be insufficient to detect a small 
lymphocele, but prospective scans of the pelvis by ultrasound, 
CT (computed tomography) scan or MRI (magnetic resonance 
imaging) offer more objective methods. 
  Several factors may contribute to this varied incidence. 
Lymphocele developmental factors are thought to include; the 
extent of lymphadenectomy, the number of lymph nodes 
removed, no ligation of lymph vessels, pre/postoperative 
radiation therapy and the presence of metastases to the lymph 
nodes (6). Other factors that may influence its development 
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include; the use of retroperitoneal suction drainage (7) and 
low-dose heparin thromboembolic prophylaxis (8).
  Although many lymphoceles are incidental findings having 
little clinical significance, some can cause problems. Whereas, 
small lymphoceles are often asymptomatic, infected or large 
collections may cause fever, abdominal pain, tenesmus, urinary 
frequency, hydronephrosis, leg edema and/or deep venous 
thrombosis (9~12). The symptomatology varies depending on 
the location of the lymphoceles and the effects of pressure on 
the surrounding structures.
  The treatment of small, uninfected lymphoceles is generally 
conservative; on the other hand, large collections are not as 
likely to be resorbed spontaneously; thus, require more 
aggressive approaches, including fine-needle aspiration, sclero-
therapy, catheter drainage and/or surgical marsupialization (13).
  In these studies, our objective was to evaluate the incidence 
of lymphocele to identify the risk factors of lymphocele 
development after a pelvic lymphadenectomy and to investigate 
their management.
MATERIALS AND METHODS
  This retrospective study was carried out on 264 gynecologic 
cancer patients who received pelvic lymphadenectomy and 
paraaortic lymphadenectomy, at the Severance Hospital, Yonsei 
University of Medical Center, Seoul, Korea, between March 
1999 and February 2003. 105 patients had cervical cancer, 115 
ovarian cancer, 40 endometrial cancer and 4 had other malig-
nancies. Patients were classified into two groups; the lympho-
cele (n=50) and the non-lymphocele groups (n=214), as 
confirmed by ultrasonography, CT scan and MRI. These groups 
were compared with respect to possible risk factors, i.e., type 
and stage of cancer, BMI (body mass index), preoperative Hb, 
the use of pre/postoperative chemotherapy or radiotherapy, the 
number of resected pelvic lymph nodes and the volume of 
postoperative drainage from a HemovacⓇ pelvic drain. The case 
records of the 50 patients with lymphocele were scrutinized for 
possible contributory factors, complications and management 
during postoperative follow-up examinations every 3~4 weeks.
    1) Surgical techniques
  Almost all primary surgeries were carried out by one 
surgeon. These involved unilateral or bilateral pelvic 
lymphadenectomies. For these patients, the lymphadenectomy 
was associated with hysterectomies, salpingooophorectomies, 
omentectomies and multiple peritoneal biopsies, with or without 
bowel resection, depending on the tumor intraabdominal spread. 
The surgical technique has been previously described by 
Benedetti-Panici et al, as follows (14). Nodes were dissected 
from vessels of the adventitia by blunt and sharp dissection. 
Vessel mobilization was performed with small waves and 
rubber tape in order to remove all the lymphofatty tissue 
surrounding the aorta, cava and pelvic vessels. Careful 
hemostasis was performed. No special effort was made to tie 
off all lymphatic channels, although surgiclips were used 
liberally during the procedure. The para-aortic lymph-
adenectomy included the removal of the lymphofatty tissue 
around and between the aorta and the cava, was performed. The 
pelvic lymphadenectomy included removal of the common 
iliac, external iliac and obturator node groups. For the purposes 
of this study, the surgical technique was modified as follows: 
the pelvic peritoneum and the peritoneum along the paracolic 
gutters were sutured with continuous 2-0 catgut (Chromic, 
Ethicon Ltd.), after reapproximation of the peritoneum. The 
fascia was closed with a running 0 polydioxanone (PDS II, 
Ethicon Ltd.) or 2-0 polyglactin 910 suture (Vicryl; Ethicon 
Ltd., Somerville, NJ) in all patients. Patients with a sutured 
peritoneum were drained with a HemovacⓇ drain (Sewoon-
medical), with or without low-pressure suction apparatus. The 
volume of fluid from each drain was measured daily. The 
drains were removed when the fluid drainage was ＜50 ml/day. 
No patient was discharged with a drain in place. A pathological 
examination was performed on lymphatic tissue and lymph 
nodes were counted and submitted for histological analysis to 
determine metastatic involvement. All patients received intraop-
erative antibiotic prophylaxis, which was continuing post-
operatively until complete ambulation had been restored. Post-
operative follow-up included assessments of febrile morbidity, 
the duration and amount of fluid drainage, and complications. 
The clinical detection of lymphoceles was documented at 
subsequent review visits. Follow-up scans were not performed 
routinely.
    2) Statistics
  Differences between the two groups were determined using 
the t-, the chi-squared and Fisher’s exact tests. Statistical 
significance was accepted at p＜0.05.
RESULTS
  Ultrasonography revealed a thin-walled pelvic “cyst” in 50 of 
the 264 patients (18%) (Fig. 1A). Lymphoceles were visualized 
as well-circumscribed oval structures, and sometimes contained 
multiple septa. Cystic structures arising from the pelvic wall, 
separate from the ovaries (when preserved), were assumed to 
be lymphoceles. CT findings of a smooth and thin-walled cavity 
filled with a water-equivalent fluid, which was sharply 
demarcated from its surroundings, and showing no signs of 
infiltration, were interpreted as lymphoceles (Fig. 1B). In MRI, 
because of their protein contents, the lymphoceles had high 
signal intensities on T2-W1. The configuration and position of 
lymphoceles, together with their signal characteristics, facilitated 
their recognition by imaging studies, particularly with a previous 
history of lymph node dissection (Fig. 1C). By physical 
examination, clinical lymphoceles were detectable in 11 of the 
50 patients. By CT scan and MRI, lymphoceles were visualized 
in 41 and 6 of the 50 patients, respectively. The time taken for 
detection of lymphoceles varied from 3 weeks to 6 months 
postoperatively, with a mean of 1.8 months. In 38 cases, the 
occurrence was unilateral (Right=15, Left=23), while in the 
other 12 cases this was bilateral.
  The incidences of lymphocele, according to primary cancer 
type, were as follows (Table 1); Pelvic lymphoceles were 
diagnosed in 18% (50 of 264) of the total study population, 
in 14% (15 of 105) of cervical cancer patients, 19% (22 of 115) 
of ovarian cancer patients and in 27% (11 of 40) of endometrial 
cancer patients. 
  Each group was compared with respect to possible risk 
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Fig. 1. Radiological examination showing lymphocele. (A) 
Ultrasonography revealed a thin-walled pelvic “cyst” 
(about 7×3 cm2 sized). Lymphoceles were visualized as 
well-circumscribed oval structures. (B) CT findings of 
a smooth and thin-walled cavity (arrow) filled with a 
water-equivalent fluid, which was sharply demarcated 
from its surroundings, and showing no signs of 
infiltration were interpreted as lymphoceles. After 
ultrasonography-guided percutaneous catheter drainage, 
a catheter (arrow head) was inserted in the lymphocele 
cavity. (C) MRI revealed an about 7×3 cm2 sized cyst, 
with low signal intensity on T1-W1.
Table 1. Incidence of lymphocele according to the primary cancer
󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚
Primary No. of No. of lymphocele %cancer cases cases
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
Cervical cancer 105 15 14.3
stage I  98 11
II   7  4
Ovarian cancer 115 22 19.1
stage I~II  72  6
III~IV  43 16
Endometrial cancer  40 11 27.5
stage I~II  29  9
III~IV  11  2
others 4  2 50.0
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
Total 264 50 (18%)
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
p=0.1
Table 2. Risk factors of lymphocele development
󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚
Lymphocele Non-lymphocele pgroup (n=50) group (n=214)
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
 43.0±8.0  46.6±10.9
Age (yr) 0.4
(23~65) (22~78)
BMI* (kg/㎡) 23.9±3.4 22.5±3.0 0.004
Preop. Hb (g/dl) 11.7±1.3 11.5±1.4 0.3
BPLD† (mean)  26.8±14.8  23.0±10.2 0.03
PALS‡ (mean)  2.4±1.8  2.5±2.6 0.6
D.Vol§ (ml)  1126±960.1  1010±824.8 0.4
MD.Vol∥ (ml) 140.2±80.8 148.7±91.8 0.6
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
*body mass index, †number of resected pelvic lymph nodes, ‡
number of resected aortic lymph nodes, §total volume of 
postoperative drainage from pelvic drain, ∥mean volume of 
postoperative drainage from a HemovacⓇ pelvic drain
factors of lymphocele development (Table 2). BMI was found 
to be significantly higher in the lymphocele (23.94±3.38 vs. 
22.52±3.00, p=0.00) than the non-lymphocele group and the 
number of resected pelvic lymph nodes was significantly higher 
in the lymphocele group (26.80±14.82 vs. 22.96±10.18, 
p=0.03). Of the 264 cases, only 32 patients were found to have 
positive nodes at surgery, 12 in the lymphocele and 20 in the 
non-lymphocele group (p=0.04). The incidence of patients with 
lymph node metastases was 12% (32 of 264). No significant 
differences were found with respect to age, preoperative Hb, 
duration until lymphocele occurrence or amount of post-
operative pelvic drainage. Patients with drains had a median 
fluid loss of 140.2±80.8 ml/day in the lymphocele and 
148.7±91.8 ml/day in the non-lymphocele group, with median 
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Table 3. Relationship of postoperative radiotherapy to lymphocele 
development
󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚
Postop. No. of No. of lymphocele %Radiotherapy cases cases
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
+  65 19 29.2
- 199 31 15.6
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
Total 264 50 (18%)
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
p=0.01
Table 4. Relationship of pre-/postoperative chemotherapy to 
lymphocele development
󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚
No. of No. of lymphoceleChemotherapy %cases cases
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
pre(-), post(-)  87 14 16.1
pre(+), post(-)  20  3 15.0
pre(-), post(+) 135 32 23.7
pre(+), post(+)  22  1 4.5
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
Total 264 50 (18%)
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
p=0.1
Table 5. Management of lymphoceles
󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚




Large size only*  2
Infection only  2
Large size with infection  1
Large size with infection, hydronephrosis  6






*＞6 cm, †deep vein thrombosis.
Table 6. Management of lymphocele related complications
󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚󰠚
Lymphocele related No. of Managementcomplications cases
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
Large size only* 2 Fine needle aspiration or
 catheter drainage
 +antibiotics
Infection only 2 Antibiotics
Large size with infection 1 Catheter drainage
 +antibiotics
Large size with infection, 6 Catheter drainage
 hydronephrosis  +antibiotics
 ±sclerotherapy
 ±ureter stent indwelling
Large size with infection, 2 Catheter drainage
 hydronephrosis and DVT†  +antibiotics
 +sclerotherapy
 +ureter stent indwelling
 ±anticoagulant therapy
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
*＞6 cm, †deep vein thrombosis.
drainage durations of 6.3 and 7.1 days, respectively.
  84 patients received postoperative radiotherapy, but no 
patient received preoperative radiotherapy, whereas 46 received 
preoperative chemotherapy and 190 postoperative chemo-
therapy and the occurrence of lymphocele was lower for those 
without postoperative radiotherapy (p=0.01) (Table 3). No 
significant differences were observed with respect to 
pre/postoperative chemotherapies (p=0.10) (Table 4).
  In our series, 13 of the 50 patients that developed lymphocele 
needed treatment for lymphocele related complications (Table 
5). In the lymphocele group (n=50), eleven of the 13 com-
plained of pelvic pain or leg swelling, and all 13 suffered from 
mild fever. Some patients had more than one symptom; 2 
developed a large (＞6 cm) lymphocele, 2 an infected 
lymphocele, 1 a large infected lymphocele, 6 an infected 
lymphocele, with hydronephrosis, and a further 2 an infected 
lymphocele, with hydronephrosis and deep vein thrombosis. Of 
the 50 lymphocele patients, 11 (22%) had a lymphocele ＜3 
cm in diameter, 26 (52%) 3~6 cm and 13 (26%) were ＞6 cm 
in diameter. All lymphoceles with a diameter of ＜6 cm were 
asymptomatic, whereas all but 13 lymphoceles with a diameter 
exceeding 6 cm were symptomatic.
  The remaining 37 patients were not treated. Regression of 
the lymphoceles occurred over several months in 25 of the 37 
patients, but persistent lymphoceles were noted in the other 12.
  Of the 13 complicated lymphocele patients, none required a 
laparotomy and marsupialization (Table 6), but all received 
antibiotic therapy. Two patients were adequately treated by 
antibiotics alone. Only one patient underwent fine-needle 
aspiration without image-guidance. Catheter drainage under 
sonographic guidance was performed in ten patients (Fig. 2). 
One patient with a single large (＞6 cm) lymphocele and 
another with a large infected lymphocele required catheter 
drainage. Of the 6 patients with a large infected lymphocele, 
with hydronephrosis, catheter drainage, with sclerotherapy and 
ureter stent indwelling, was performed in 2 cases, catheter 
drainage with sclerotherapy in 1, catheter drainage with ureter 
stent indwelling in 2 and catheter drainage alone in a further 
case. Of the two patients with a large infected lymphocele, with 
hydronephrosis and deep vein thrombosis, one received catheter 
drainage with sclerotherapy and ureter stent indwelling and in 
the other, additional anticoagulant therapy was needed. No 
patient experienced sepsis, bowel perforation or neurovascular 
injury. Catheter drainage allowed complete clinical and 
radiological remission in all cases (Fig. 3A,B), which was 
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Fig. 2. Fluoroscopy-guided percutaneous catheter drainage (after 
pelvic sonography). Arrow head; catheter
Fig. 3. Percutaneous catheter drainage. (A) Large (about 11×7 cm2 sized) lymphocele were managed using sonography-guided placement 
of a percutaneous catheter, with drainage. The catheter (arrow head) is at the left, within the lymphocele. (B) Catheter drainage 
allowed complete radiological remission in this case. Arrow head; catheter.
tolerated and caused no side effects at either the short- or 
long-term follow-ups. 
DISCUSSION
  A lymphocele is a retroperitoneal collection of lymphatic fluid 
contained within a sac, which commonly arise secondary to 
lymphatic channel injury (1,2,15). A lymphocele occurs after 
renal transplantation and surgery due to prostatic, gynecologic 
malignancies, a vascular disease (15,16) or lymphatic vessel 
injury after a pelvic lymphadenectomy. In the present study, all 
lymphoceles were located in the pelvis, thus confirming that the 
rarity of aortic lymphoceles (17,18). Moreover, the incidence 
of lymphoceles was found to be similar for pelvic lympha-
denectomies, with or without a para-aortic lymphadenectomy. 
These findings suggest that lymphoceles are a specific 
complication of pelvic lymphadenectomies (2,9). Following the 
removal of lymph nodes and adipose tissue, a space or potential 
space is formed, which is bounded by the denuded musculature, 
both laterally and posteriorly, and by the peritoneum medially 
(9). Although this space is spontaneously obliterated in the 
majority of patients, lymph accumulation occurs in others. The 
resulting mass varies in size, and may apply variable pressures 
on the ureter, bladder, rectosigmoid and blood vessels. In the 
majority of patients these effects may be minimal (i.e., 
asymptomatic), and are rarely severe enough to interfere with 
organ function.
  Lymphoceles have occurred in approximately 10 to 25% of 
previous studies, and in most are asymptomatic and disappear 
spontaneously (2,5,19). However, in 5 to 10% of patients, the 
lymphoceles become symptomatic, manifesting fever, pain, 
constipation, prolonged ileus, urinary frequency, obstructive 
uropathy, leg edema, erythema of overlying skin or deep vein 
thrombosis (11,20). In our series, the incidence rate of 
symptomatic lymphocele was 18% (Table 1), which was 
comparable with the rates reported by Conte et al. (3) and Petru 
et al. (17), although is rather high compared with figures 
published more recently (14,21). However, our series included 
both symptomatic and progressive asymptomatic cases, which 
undoubtedly influenced the observed incidence of lymphoceles. 
  Lymphoceles can be detected by clinical examination, 
ultrasonography, intravenous urography, CT scan or MRI. The 
differential diagnosis includes; urinoma, seroma, hematoma, 
abscess and a cystic neoplasm. Lymphoceles typically become 
detectable within 3~8 weeks postoperatively (3,20). Those that 
occur later than 1 year after surgery should be suspected of 
harboring a recurrent disease, although in our experience 
lymphocele development has not occurred more than 1 year 
after surgery. Most of the lymphoceles in the present series 
regressed spontaneously; 37 of the 50 patients that underwent 
a CT scan showed resolution or a decreased size.
  The formation of lymphoceles may be promoted by several 
factors: the extent of lymphadenectomy (9,10,12), the number 
of lymph nodes removed (22,23); no ligation of lymph vessels 
(24); the presence of metastases to the lymph nodes (9); 
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pre/postoperative radiation therapy (8,11) and the prophylactic 
use of anticoagulants (11). However, none of these potential 
factors have been proven to be significant. In our series, the 
lymphocele and non-lymphocele groups were significantly 
different in terms of the number of resected lymph nodes, BMI 
and the use of postoperative radiotherapy (Table 2, 3). Efforts 
to prevent lymphocele formation have only been partially 
successful. Such methods include; strict indications and 
well-defined dissection boundaries, retroperitoneal suction 
drainage (7,16), and the prophylactic use of antibiotics (11).
  The treatment of lymphocele should be individualized. If 
they are asymptomatic, they should be monitored for 
spontaneous regression. In the majority of cases this will lead 
to successful resolution, as in the present series. However, 
regression may be a slow process; occurring over several 
months. The management of lymphoceles has involved several 
strategies, including percutaneous needle aspiration, percuta-
neous catheter drainage, sclerotherapy and open drainage by 
laparotomy, as well as laparoscopy. Asymptomatic lymphoceles 
＜100 ml can be followed clinically, and will usually resolve 
spontaneously. Lymphoceles that persist for ＞6 months or 
become symptomatic can be reduced by ultrasonography or CT 
scan-guided percutaneous needle aspiration. The decision to 
puncture a lymphocele depends mainly on its location. 
Aspirated fluids should be sent for chemistry, cytology and 
culture, in order to establish a diagnosis and rule out 
malignancy or infection. Large or recurrent lymphoceles may 
be managed by sonography or CT scan-guided placement of a 
percutaneous catheter, with drainage. The catheter is left within 
the lymphocele until drainage has diminished to 50 ml per 24h 
and lymphocele resolution has been demonstrated radiographi-
cally. The morbidity associated with this procedure is lower 
than those of invasive surgical procedures, with the successful 
resolution of lymphoceles using this method having been 
reported in between 79 and 82% of cases (19). Ultrasonography 
or CT scan-guided percutaneous aspiration, followed with 
sclerotherapy, is another treatment modality. Some studies have 
described lymphocele treatment by percutaneous catheter 
drainage and sclerotherapy with 95% absolute ethanol, 105 
povidone iodine solution, tetracycline, sodium tetradecyl 
sulfate, or doxycycline. Lymphoceles rarely require a laparoto-
my and intraperitoneal marsupialization. For infected lympho-
celes, antibiotics alone are often sufficient. However, the 
identities of the common pathogens that cause a lymphocele 
infection, and the route of the infection, remain unclear. 
However, infections are largely of theoretical concern, as they 
may occur in the early postoperative period during the 
re-epithelization process and related to the accumulation of 
fluids (25). In our series, 13 of the 50 patients with lympho-
celes needed treatment due to lymphocele related complications 
(Table 5, 6); the remaining 37 were not treated. No patient 
required a laparotomy and marsupialization. All 13 treated 
patients were administered antibiotics. Two patients responded 
adequately to antibiotic treatment alone. Only one patient 
underwent fine-needle aspiration without image-guidance. 
Catheter drainage under sonographic guidance was performed 
in ten patients. No patient experienced sepsis, bowel perforation 
or neurovascular injury.
  Serial radiological examinations in the patients that 
underwent pelvic and para-aortic lymphadenectomies allowed 
for the early detection and treatment of symptomatic and 
progressive asymptomatic collections, which possibly reduced 
the duration of therapy and the risk of further complications. 
However, most lymphocele patients are asymptomatic, and 
rarely needed treatment. Therefore, it is our belief that close 




  In the present study, of the 264 patients, 50 (18%) developed 
lymphoceles, and it was indicated that the number of resected 
lymph nodes, the BMI and use of postoperative radiotherapy 
should be viewed as risk factors for lymphocele development. 
In the lymphocele group (n=50), 13 patients needed treatment 
due to lymphocele-associated complications.
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